Join the Hepatitis C group to help and get support from people like you.
Hepatitis C News (Page 2)
Related terms: Hepatitis C, Chronic, Chronic Hepatitis C, Hep C
Hepatitis C Treatments: A Comprehensive Guide
THURSDAY, July 6, 2023 – Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly...
CDC: Cure for Hepatitis C Out of Reach for Many
THURSDAY, June 29, 2023 – More than 2 million people in the United States have hepatitis C, but most are not getting the safe treatment that can cure the disease, according to research published in...
Hepatitis C Can Kill, But Too Many Can't Access the Cure
THURSDAY, June 29, 2023 – More than 2 million people in the United States have hepatitis C, but most are not getting the safe treatment that can cure the disease, public health officials said...
How Do You Get Hepatitis C? Here’s What to Know
WEDNESDAY, June 14, 2023 – Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical. The American Liver Foundation estimates that it...
Is There a Cure for Hepatitis C Infection?
MONDAY, June 12, 2023 – Hepatitis C is a serious viral infection that can damage your liver over time, but is there a cure for this insidious disease? Over 2 million adults in the United States are...
There's No Hepatitis C Vaccine, But You Can Still Prevent Infection
MONDAY, June 12, 2023 – Hepatitis C can ruin your liver, and there's no vaccine to prevent it, but you can take steps to lower your chances of infection. According to the U.S. Centers for Disease...
What Are the Symptoms of Hepatitis C?
MONDAY, June 12, 2023 – Hepatitis C is often missed in the early stages of infection, so you need to know what symptoms might spell trouble. According to the U.S. Centers for Disease Control and...
Your Guide to Hepatitis C Medications
THURSDAY, June 8, 2023 – Hepatitis C is a serious viral infection that can scar your liver, cause your liver to fail and raise your risk for liver cancer, but there are a multitude of medications...
Need Accurate Info on Liver Disease? Don't Head to TikTok
TUESDAY, May 9, 2023 – About 4.5 million adults in the United States have liver disease. If they're looking for information about their condition, they'd be wise to look beyond TikTok, new research...
U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric...
FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for...
FDA Approves Mavyret (glecaprevir/pibrentasvir) Treatment Duration of Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
NORTH CHICAGO, Ill., Sept. 26, 2019 /PRNewswire/ – AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Medwatch Alert: FDA Warns About Rare Occurrence of Serious Liver Injury with Use of Hepatitis C Medicines Mavyret, Zepatier, and Vosevi in Some Patients with Advanced Liver Disease
August 28, 2019 – The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver...
FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
April 30, 2019 -- The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. ...
FDA Approves Expanded Labeling for Epclusa (sofosbuvir/velpatasvir) for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 1, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Epclusa® ...
Ask a question
To post your own question to this support group, sign in or create an account.